Friday 6 November 2026
Export EHC’s income statement to Excel — free account
Encompass Health Corporation
EHC Healthcare Medical Care Facilities
Encompass Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.9 billion, up 10.5% from fiscal 2024.
- Revenue
- +8.93%
- EPS
- +20.6%
- Free cash flow
- +52.3%
- Total debt
- +6.83%
Quarter to September 2026, against a year earlier
138.07
3.20
−2.27%
Follow EHC
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
18.85 | 15.91 | 16.25 | 18.75 |
P/S ratio |
1.80 | 1.58 | 1.61 | 1.88 | |
P/FCF ratio |
26.04 | 22.07 | 26.02 | 27.93 | |
P/Operating CF |
30.83 | 30.65 | 35.34 | 32.99 | |
P/B ratio |
3.32 | 2.90 | 2.93 | 3.41 | |
Price to Tangible BV |
6.70 | 5.68 | 5.63 | 6.36 | |
EV/Sales |
2.20 | 1.98 | 2.01 | 2.28 | |
EV/EBITDA |
9.39 | 8.38 | 8.50 | 9.45 | |
EV/Operating CF |
11.10 | 10.00 | 10.30 | 11.08 | |
EV/FCF |
31.87 | 27.61 | 32.54 | 33.77 | |
Quick Ratio |
0.86 | 0.96 | 0.94 | 0.88 | |
Current Ratio |
1.08 | 1.17 | 1.19 | 1.09 | |
Net Debt/EBITDA |
6.29 | 6.20 | 6.66 | 6.51 | |
Debt/Assets |
35.13% | 35.19% | 35.32% | 34.35% | |
Debt/Equity |
0.77 | 0.78 | 0.77 | 0.74 | |
Asset Turnover |
0.87 | 0.87 | 0.87 | 0.88 | |
Operating CF/Net income |
2.36 | 1.61 | 1.84 | 2.41 | |
Capex/Depreciation |
(2.39) | (1.86) | (2.44) | (2.45) | |
Interest Coverage |
9.38 | 9.48 | 8.70 | 8.94 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
60.47% | 59.28% | 59.41% | 59.99% | |
Intangible Assets out of Total Assets |
0.23 | 0.22 | 0.22 | 0.21 | |
Share Based Compensation of Revenue |
1.19% | 0.72% | 0.86% | 0.93% | |
Graham Net Nets |
(0.28) | (0.31) | (0.30) | (0.26) | |
Graham Number |
63.68 | 67.55 | 69.43 | 72.08 | |
Earnings Yield |
5.30% | 6.29% | 6.15% | 5.33% | |
Free Cash Flow Yield |
3.84% | 4.53% | 3.84% | 3.58% | |
Revenue per Share |
15.37 | 15.99 | 16.17 | 16.37 | |
Operating CF per Share |
3.44 | 3.16 | 2.86 | 3.68 | |
Capex per Share |
(2.28) | (1.64) | (2.23) | (2.39) | |
Free Cash Flow per Share |
1.16 | 1.52 | 0.63 | 1.30 | |
Cash per Share |
1.02 | 1.65 | 1.35 | 1.02 | |
Shareholders Equity per Share |
32.01 | 33.35 | 34.45 | 35.63 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
32.01 | 33.35 | 34.45 | 35.63 | |
Free Cash Flow |
116.70 | 150.70 | 62.30 | 127.50 | |
Working Capital |
69.50 | 152.30 | 167.60 | 85.60 | |
Capital Expenditures |
(229.30) | (162.40) | (220.30) | (234.50) | |
Net Current Asset Value |
(2,966.30) | (2,975.70) | (3,013.30) | (3,050.90) | |
EV/EBIT |
12.40 | 11.04 | 11.21 | 12.47 | |
Capex to Sales |
0.15 | 0.10 | 0.14 | 0.15 | |
Price to Operating Income |
10.13 | 8.82 | 8.97 | 10.31 | |
| Other line items | |||||
Average Receivables |
609.00 | 649.70 | 649.90 | 661.40 | |
Average Payables |
174.60 | 181.55 | 198.05 | 184.90 | |
Average Assets |
6,812.20 | 6,977.25 | 7,121.60 | 7,216.10 | |
Average Common Equity |
3,005.10 | 3,094.95 | 3,218.15 | 3,317.25 |
Columns are period end dates · fundamentals updated 5 Nov 2026